British singer Lily Allen’s appearance as the musical guest on NBC's Saturday Night Live on Saturday night sparked a sharp backlash from some viewers, with social media users questioning her vocals, ...

Eli Lilly is positioned for a secular growth trajectory, leveraging its duopoly in diabetes and obesity therapies while investing heavily in pipeline diversification. LLY faces intensifying ...

Why has Jon Hamm been dancing in ecstasy all over your Instagram and TikTok feeds lately? Well, it's a story that starts with an Apple TV show from earlier this year and ends with Millennial nostalgia ...

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug. By Gina Kolata Gina Kolata has ...

Retatrutide shows highest weight loss to date in trial Lilly says trial departures due to perceived excessive weight loss Retatrutide shows elevated skin-related side effects Dec 11 (Reuters) - Eli ...

Dec 10 (Reuters) - French biotech company Abivax's (ABVX.PA), opens new tab shares rose by over 20% on Wednesday on market rumours that U.S. pharma giant Eli Lilly (LLY.N), opens new tab could make an ...

Shares of French biotech Abivax (ABVX) climbed in Paris on Wednesday, in a move Reuters attributed to market speculation about a potential takeover bid from weight-loss drugmaker Eli Lilly (LLY). The ...

Eli Lilly LLY0.09%increase; green up pointing triangle plans to build a $6 billion facility in Huntsville, Ala., to make active pharmaceutical ingredients, including those used in weight-loss drugs.

Eli Lilly and Company announced Tuesday it was investing more than $6 billion in a new manufacturing facility in Huntsville, Alabama. The next-generation synthetic medicine active pharmaceutical ...

HUNTSVILLE, Ala. — Pharmaceutical giant Eli Lilly and Company announced Tuesday a massive $6 billion investment to build a next-generation manufacturing facility in Huntsville, marking the largest ...